Effective Strategies in Developing Accelerator Models April 22, - - PowerPoint PPT Presentation
Effective Strategies in Developing Accelerator Models April 22, 2013 Richard A. Bendis President & CEO BioHealth Innovation, Inc. The Region: Central Maryland Unrivaled Research Assets 59 Federal Laboratories, Centers, and Institutes
Richard A. Bendis
President & CEO BioHealth Innovation, Inc.
April 22, 2013
Unrivaled Research Assets Annual Maryland R&D Investment
59 Federal Laboratories, Centers, and Institutes
JHU/USM: $3.5 billion Federal: $12 billion
Electronic Medical Records
Technology Focus
E-Health BioHealth Cyber Security Healthcare Services Health Informatics Medical Devices Mobile Health Therapeutics Diagnostics
Align local technologies, assets and resources to advance innovation
Regionally-oriented Private-public partnership 501(c)(3) nonprofit Market-driven Private sector-led
PROOF OF COMMERCIAL RELEVANCE UNIVERSITIES, FEDERAL GRANTS, PRIVATE R&D, BASIC RESEARCH, INVENTIONS
PUBLICATIONS PhD's TENURE PATENTS
WEALTH CREATION: COMPANIES, JOBS, PRODUCTS & PROFITS FUNDING & ENTREPRENEURIAL RESOURCES MAKE TECHNOLOGY INVESTMENT GRADE
6
PROOF OF CONCEPT
2
PRODUCT DEVELOPMENT RESEARCH
3
PROTOTYPE PRODUCT
4
GENERATE EQUITY, ROYALITIES, & LICENSE FEES
8
NEXT GENERATION PRODUCTS
9
REINVESTMENT
10 1
SPINOFF COMPANIES TRANSFER TECHNOLOGY TO INDUSTRY
7 5
BHI Commercialization Model
Proof of
CONCEPT
(Technological Feasibility) Laboratory Push “It Works!”
PROOF OF
COMMERCIAL RELEVANCE
(Market Pull) “It Works To Solve A Problem” “I’ll Buy It”
An active partner with research institutions
13 Years Scientific 4 Years Financial / Venture Capital 13 Years Entrepreneurial Management
Drugs Vaccines Diagnostics Therapeutics Medical Devices
Health IT
+ 30 NIH Postdocs and Interns
Innovations identified
Innovations progressed
Innovations in Primary Analysis
Advanced Personalized Diagnostics, LLC
Offers chemosensitivity profiling services to provide personalized treatment plans Personalized Cancer Care
Ahead Research, Inc.
Web/Mobile application that matches patients to high quality healthcare providers Personalized Diagnostics
Mimetas
Organ-on-a-Chip solutions as an early screening model to predict toxic side effects and drug efficacy Pharmaceutical
Perceptive Navigation, LLC
Develops medical devices related to image-guided, minimally-invasive markets Medical Device
Industry EIR Health Information Technology EIR University of Maryland Ventures EIR National Cancer Institute National Institutes of Health National Heart Lung and Blood Institute
Supply Stage Demand
Pre-Seed Seed/Start-Up Early Later $0K $2.5M $5.0M
VALLEY OF DEATH
$500K
Source
Founders, FFF, Bootstrapping, Crowdfunding Angels, IBED, SBIR, Accelerator Seed Funds Venture Funds, M&A, IPO
SBIR/STTR Assistance Program BHI Angel Fund BHI Commercial Relevance Investment Fund
Help companies prepare high-quality SBIR/STTR grant proposals. Bridge the gap between pre-seed investments and institutional venture capital. Pre-seed and early-stage, equity-based innovation capital fund to help grow companies
An intensive 16-week program for top-recruited companies and entrepreneurs
Provides a network of experienced mentors in:
Business Marketing Product Development
ACADEMIA
INDUSTRY
GOVERNMENT
FOUNDATIONS
INSEPARABLE MISSIONS
Cell: (215) 594-3333 Office: (301) 637-6439 Email: rbendis@bendisig.com
”The BHI EIR program represents a significant paradigm shift in the way NIH hopes to advance commercially relevant science.”